147 related articles for article (PubMed ID: 37847267)
21. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
[TBL] [Abstract][Full Text] [Related]
22. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
Ophthalmol Retina; 2018 Jan; 2(1):38-45. PubMed ID: 31047300
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy.
Graham PS; Kaidonis G; Abhary S; Gillies MC; Daniell M; Essex RW; Chang JH; Lake SR; Pal B; Jenkins AJ; Hewitt AW; Lamoureux EL; Hykin PG; Petrovsky N; Brown MA; Craig JE; Burdon KP
BMC Med Genet; 2018 May; 19(1):71. PubMed ID: 29739359
[TBL] [Abstract][Full Text] [Related]
24. Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.
Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
PLoS One; 2016; 11(8):e0161897. PubMed ID: 27564383
[TBL] [Abstract][Full Text] [Related]
25. Maintenance of Vision Needed to Drive after Intravitreal Anti-VEGF Therapy in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema.
Emami-Naeini P; Garmo V; Boucher N; Fernando R; Menezes A
Ophthalmol Retina; 2024 Apr; 8(4):388-398. PubMed ID: 37866681
[TBL] [Abstract][Full Text] [Related]
26. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study.
Lois N; Cook JA; Wang A; Aldington S; Mistry H; Maredza M; McAuley D; Aslam T; Bailey C; Chong V; Ganchi F; Scanlon P; Sivaprasad S; Steel DH; Styles C; Azuara-Blanco A; Prior L; Waugh N;
Ophthalmology; 2021 Apr; 128(4):561-573. PubMed ID: 33130144
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Handheld Retinal Imaging with ETDRS 7-Standard Field Photography for Diabetic Retinopathy and Diabetic Macular Edema.
Salongcay RP; Aquino LAC; Salva CMG; Saunar AV; Alog GP; Sun JK; Peto T; Silva PS
Ophthalmol Retina; 2022 Jul; 6(7):548-556. PubMed ID: 35278726
[TBL] [Abstract][Full Text] [Related]
29. The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.
Lei C; Zhang Y; Zhang M
Front Endocrinol (Lausanne); 2022; 13():764254. PubMed ID: 35937830
[TBL] [Abstract][Full Text] [Related]
30. Proteome Changes Associated with the VEGFR Pathway and Immune System in Diabetic Macular Edema Patients at Different Diabetic Retinopathy Stages.
Han R; Gong R; Liu W; Xu G
Curr Eye Res; 2022 Jul; 47(7):1050-1060. PubMed ID: 35435079
[TBL] [Abstract][Full Text] [Related]
31. Brain-derived neurotrophic factor in non-proliferative diabetic retinopathy with diabetic macular edema.
Jun YH; Kim ST
Eur J Ophthalmol; 2021 Jul; 31(4):1915-1919. PubMed ID: 32686489
[TBL] [Abstract][Full Text] [Related]
32. Three-Dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography.
Adhi M; Badaro E; Liu JJ; Kraus MF; Baumal CR; Witkin AJ; Hornegger J; Fujimoto JG; Duker JS; Waheed NK
Am J Ophthalmol; 2016 Feb; 162():140-149.e1. PubMed ID: 26548809
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy.
Chen H; Zhang X; Liao N; Ji Y; Mi L; Gan Y; Su Y; Wen F
Front Endocrinol (Lausanne); 2022; 13():1020252. PubMed ID: 36465606
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives.
Bursell SE; Fonda SJ; Lewis DG; Horton MB
PLoS One; 2018; 13(6):e0198551. PubMed ID: 29924846
[TBL] [Abstract][Full Text] [Related]
35. Is immediate treatment necessary for diabetic macular edema after pars plana vitrectomy for tractional complications of proliferative diabetic retinopathy?
Behera UC; Das T; Sivaprasad S; Rani PK; Raman R; Agarwal M; Agarwal T; Sahu S; Vaidya H; Panchal B;
Int Ophthalmol; 2021 Nov; 41(11):3607-3614. PubMed ID: 34170479
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain).
Rodriguez-Poncelas A; Miravet-Jiménez S; Casellas A; Barrot-De La Puente JF; Franch-Nadal J; López-Simarro F; Mata-Cases M; Mundet-Tudurí X
Br J Ophthalmol; 2015 Dec; 99(12):1628-33. PubMed ID: 26089211
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
38. Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy.
Shaikh NF; Vohra R; Balaji A; Azad SV; Chawla R; Kumar V; Venkatesh P; Kumar A
Indian J Ophthalmol; 2021 Nov; 69(11):3218-3224. PubMed ID: 34708776
[TBL] [Abstract][Full Text] [Related]
39. Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice.
Moshfeghi A; Garmo V; Sheinson D; Ghanekar A; Abbass I
Clin Ophthalmol; 2020; 14():3651-3659. PubMed ID: 33154625
[TBL] [Abstract][Full Text] [Related]
40. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
